Elucidation of disease etiology by trans-layer omics analysis

Abstract To date, genome-wide association studies (GWASs) have successfully identified thousands of associations between genetic polymorphisms and human traits. However, the pathways between the associated genotype and phenotype are often poorly understood. The transcriptome, proteome, and metabolom...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuya Shirai (Author), Yukinori Okada (Author)
Format: Book
Published: BMC, 2021-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2fc50e17f9ad4ca7a5c73201bc6e3dfe
042 |a dc 
100 1 0 |a Yuya Shirai  |e author 
700 1 0 |a Yukinori Okada  |e author 
245 0 0 |a Elucidation of disease etiology by trans-layer omics analysis 
260 |b BMC,   |c 2021-02-01T00:00:00Z. 
500 |a 10.1186/s41232-021-00155-w 
500 |a 1880-8190 
520 |a Abstract To date, genome-wide association studies (GWASs) have successfully identified thousands of associations between genetic polymorphisms and human traits. However, the pathways between the associated genotype and phenotype are often poorly understood. The transcriptome, proteome, and metabolome, the omics, are positioned along the pathway and can provide useful information to translate from genotype to phenotype. This review shows useful data resources for connecting each omics and describes how they are combined into a cohesive analysis. Quantitative trait loci (QTL) are useful information for connecting the genome and other omics. QTL represent how much genetic variants have effects on other omics and give us clues to how GWAS risk SNPs affect biological mechanisms. Integration of each omics provides a robust analytical framework for estimating disease causality, discovering drug targets, and identifying disease-associated tissues. Technological advances and the rise of consortia and biobanks have facilitated the analyses of unprecedented data, improving both the quality and quantity of research. Proficient management of these valuable datasets allows discovering novel insights into the genetic background and etiology of complex human diseases and contributing to personalized medicine. 
546 |a EN 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Inflammation and Regeneration, Vol 41, Iss 1, Pp 1-7 (2021) 
787 0 |n https://doi.org/10.1186/s41232-021-00155-w 
787 0 |n https://doaj.org/toc/1880-8190 
856 4 1 |u https://doaj.org/article/2fc50e17f9ad4ca7a5c73201bc6e3dfe  |z Connect to this object online.